129 related articles for article (PubMed ID: 2891021)
1. Terazosin for hypertension.
Med Lett Drugs Ther; 1987 Dec; 29(755):112-3. PubMed ID: 2891021
[No Abstract] [Full Text] [Related]
2. [Terazosin].
Schäfers RF; Michel MC
Dtsch Med Wochenschr; 1998 Apr; 123(15):459-60. PubMed ID: 9581161
[No Abstract] [Full Text] [Related]
3. Terazosin in mild hypertension: experience in open trials.
Rosenthal J
Br J Clin Pract Suppl; 1987 Dec; 54():32-44. PubMed ID: 2905160
[No Abstract] [Full Text] [Related]
4. Terazosin for BPH.
Jerant AF
J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204
[No Abstract] [Full Text] [Related]
5. Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.
Pool JL; Nelson EB; Taylor AA; Mitchell JR
Br J Clin Pract Suppl; 1987 Dec; 54():9-14. PubMed ID: 2905162
[No Abstract] [Full Text] [Related]
6. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
Sivkov AV; Apolikhin OI; Medvedev AA
Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
[No Abstract] [Full Text] [Related]
7. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
[TBL] [Abstract][Full Text] [Related]
8. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
Frishman WH; Eisen G; Lapsker J
Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of terazosin.
Cohen J
J Clin Pharmacol; 1993 Mar; 33(3):272-8. PubMed ID: 8096524
[No Abstract] [Full Text] [Related]
10. Terazosin for benign prostatic hyperplasia.
Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075
[No Abstract] [Full Text] [Related]
11. Alpha 1-blockade in the management of hypertension.
Horky K
J Clin Pharmacol; 1993 Sep; 33(9):874-8. PubMed ID: 7901241
[No Abstract] [Full Text] [Related]
12. First European review of terazosin. Proceedings of a symposium. Reykjavik, Iceland, 29th-31st May 1987.
Br J Clin Pract Suppl; 1987 Dec; 54():1-69. PubMed ID: 2905157
[No Abstract] [Full Text] [Related]
13. Severe cutaneous reaction due to terazosin.
Hernández-Cano N; Herranz P; Lázaro TE; Mayor M; Casado M
Lancet; 1998 Jul; 352(9123):202-3. PubMed ID: 9683215
[No Abstract] [Full Text] [Related]
14. Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.
Somberg JC; Achari R; Laddu AR
Am Heart J; 1991 Sep; 122(3 Pt 2):901-5. PubMed ID: 1678920
[TBL] [Abstract][Full Text] [Related]
15. [In what sense are alpha 1-receptor blockers as first choice agents in treatment of hypertension suitable?].
Düsing R
Internist (Berl); 1996 Sep; 37(9):941. PubMed ID: 8964692
[No Abstract] [Full Text] [Related]
16. Advances in the management of hypertension: focus on terazosin, a new alpha1-adrenergic antagonist. May 3-5, 1985, Boca Raton, Florida.
Am J Med; 1986 May; 80(5B):1-105. PubMed ID: 2872798
[No Abstract] [Full Text] [Related]
17. [Terazosine in the treatment of benign prostatic hypertrophy].
Caine M
J Urol (Paris); 1993; 99(6):311-3. PubMed ID: 7516376
[TBL] [Abstract][Full Text] [Related]
18. The relationship between terazosin dose and blood pressure response in hypertensive patients.
Achari R; Hosmane B; Bonacci E; O'Dea R
J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
[TBL] [Abstract][Full Text] [Related]
19. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia].
Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P
Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
